about
The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cellsMoving forward moving backward: directional sorting of chemotactic cells due to size and adhesion differencesSurface protein gradients generated in sealed microchannels using spatially varying helium microplasmaThe phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck.Patterning microscale extracellular matrices to study endothelial and cancer cell interactions in vitro.Metastasis: recent discoveries and novel treatment strategies.Role of cytokines in head and neck squamous cell carcinoma.Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy.Biomolecular gradients in cell culture systems.ArgBP2 and the SoHo family of adapter proteins in oncogenic diseasesCarcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver.3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments.1,25-Dihydroxyvitamin D(3) regulates PTHrP expression via transcriptional, post-transcriptional and post-translational pathways.EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.The lichen secondary metabolite atranorin suppresses lung cancer cell motility and tumorigenesisRole of SOCS-1 Gene on Melanoma Cell Growth and Tumor Development.Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy.Mimicking Embedded Vasculature Structure for 3D Cancer on a Chip Approaches through Micromilling.Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration.Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3 gene expression in primary breast cancer.PKCα take part in CCR7/NF-κB autocrine signaling loop in CCR7-positive squamous cell carcinoma of head and neck.
P2860
Q24595836-8B6D9F8C-4722-4E69-BD8A-93DD1E2900FAQ27339869-A4A7BF65-D42C-42EF-BD89-B5D1F919CC50Q35107053-B4285187-C1C1-41D0-B744-EA9B1106974AQ36219713-DDB4795E-4FE7-430E-8221-7A41AD7B89A2Q36407201-1CFCAC2C-0923-40AC-BB4F-4FF109B34C00Q36407511-4ED21963-AFA9-44FB-8B3C-F795908E9461Q36613975-45B0B90E-82E9-47E7-A0AA-44C8408CA4ACQ37015155-FD067980-9039-4C8D-8C3B-82382B66710FQ37038439-B7C5F9C1-71C1-40FE-9084-82D624AB55A7Q37406767-980E777E-E77F-46BC-B625-B3BC4D847C99Q37929021-D2E0E5BC-CBBA-4FD3-8F96-EF595FABD669Q39076663-EA5DF13E-210C-47C6-AE7F-44527F4254AFQ39526606-6FEC627F-7B61-400A-A2C7-C62485527316Q39827903-BE56AB20-1B6E-46AE-8BAF-561B299EB68DQ41421514-B6AFC5CA-9CAB-4A6B-9832-B384D3DBBCB2Q42709078-CA0B754C-CC48-4739-A4FE-01B6D75DB0F8Q44221566-7ED11FDC-EDEE-4F3B-8F53-78AD25994C20Q47104048-F60B2123-E422-4B6C-93A2-F2EA331A3433Q48009486-629E341A-132F-43A0-8764-7253338DBA61Q54462431-4391C4A8-B1B2-40DC-B6EC-76300D97779FQ54576025-17193C69-F668-44CA-B5FE-EA119DDF2DFD
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Targeting key steps in metastatic tumour progression.
@ast
Targeting key steps in metastatic tumour progression.
@en
Targeting key steps in metastatic tumour progression.
@nl
type
label
Targeting key steps in metastatic tumour progression.
@ast
Targeting key steps in metastatic tumour progression.
@en
Targeting key steps in metastatic tumour progression.
@nl
prefLabel
Targeting key steps in metastatic tumour progression.
@ast
Targeting key steps in metastatic tumour progression.
@en
Targeting key steps in metastatic tumour progression.
@nl
P1476
Targeting key steps in metastatic tumour progression.
@en
P2093
Suzanne A Eccles
P356
10.1016/J.GDE.2004.12.001
P577
2005-02-01T00:00:00Z